Skip to content

Funding
Launch
Partnership
Acquisition
Policy
Exit & IPO

MSD

MSD Secures Reimbursement Approval for Von Hippel-Lindau Treatment in Italy

June 8, 2026 by Marco Bianchi

MSD’s belzutifan treatment for Von Hippel-Lindau syndrome receives reimbursement approval in Italy

Categories Launch Tags Healthtech, Italy, MSD Leave a comment

Browse by Country

Latest

Italian FinTech Unicorn Satispay Targets €120 Million Funding Round to Expand Financial Services PlatformJun 11, 2026

Romanian Kebab Chain Dristor Kebap Launches €5 Million Funding Round via SeedBlinkJun 11, 2026

Swedish Entrepreneurs Acquire Bonti and Köpbarnvagn Baby Store ChainsJun 11, 2026

Polish Fintech sunbay.io Secures €550K Seed Funding to Streamline Invoice CollectionJun 11, 2026

Amsterdam Healthtech Startup OurMind Secures €2.1 Million to Combat Healthcare Provider BurnoutJun 11, 2026

EU Markets

AI Infrastructure Billions, Banking Consolidation, and a SpaceX IPO Frenzy: What Europe's Financial Markets Mean for Startups This WeekJun 5, 2026

AI, Regulation, and Capital Shifts: What Europe's Financial Markets Mean for Your Startup This WeekMay 29, 2026

AI Debt Warnings, Blockchain Settlements, and Market Volatility: What European Founders Need to Know This WeekMay 23, 2026

Defence Tech Surges, Unicorns Emerge, and Europe's AI Funding Story Keeps Getting BiggerMay 22, 2026

EU Startups News

• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.